Search
Evogene Ltd
EVGNAdd to Watchlist
0.375USD
-0.005-1.32%
Close 10-30 16:00（ET）
5.10MMarket Cap
LossP/E TTM
Evogene Ltd (EVGN) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Evogene Ltd in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
2.150USD+474.25%
EVGN Analyst Recommendation Trends
In the current month, EVGN has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EVGN average Analyst price target in the last month is 2.150.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
EVGN Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
11
8
0
0
23
Financial Forecasting
Based on analysts' estimates, EVGN EPS is projected to reach -0.190 in FY2026Q3, following reported EPS of -0.135 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.26
-0.27
-0.27
-0.19
-0.20
Actual
-0.61
-0.60
-0.14
--
--
Surprise
-133.88%
-123.25%
+49.86%
--
--
FAQs
What is Evogene Ltd's expected revenue for the next quarter?
Evogene Ltd's expected revenue is 365.00K.
What is Evogene Ltd's price target?
Analysts forecast that Evogene Ltd's price target is USD 2.15, with the highest forecast at USD 2.15 and the lowest forecast at USD 2.15.
How have Evogene LtdEVGN's recent earnings per share performed?
The market expectation was USD -0.14, while Evogene LtdEVGN's earnings per share (EPS) for the previous quarter was USD -0.60. EPS for the next quarter is expected at USD -0.19.
What is the analyst rating for Evogene Ltd?
Based on the ratings of Evogene Ltd's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.